Medical Properties Trust price target lowered to $5 from $8 at RBC Capital

RBC Capital analyst Michael Carroll lowered the firm’s price target on Medical Properties Trust to $5 from $8 and keeps an Outperform rating on the shares. Medical Properties is a speculative stock, and the firm anticipates volatility given the market’s need to understand the potential path to a Steward resolution and asset sales timing to improve liquidity, along with the possibility of another dividend cut, the analyst tells investors in a research note.